# Mitsubishi Chemical Group

Mitsubishi Chemical Group is a Corporate Investor based in Tokyo, Japan.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Tokyo, Japan
- **Region:** Asia
- **Address:** 1-1-1 Marunouchi, Chiyoda-ku, Tokyo 100-8251, Japan
- **Founded:** 2005
- **Assets under management:** Undisclosed
- **Website:** mcgc.com
- **LinkedIn:** https://www.linkedin.com/company/mcgc-official
- **Wikidata:** Q3107966

## Regulatory record

- **Reports private funds:** No

## About

Founded in 2005 through the integration of Mitsubishi Chemical Corporation and Mitsubishi Pharma, Mitsubishi Chemical Group emerged as a diversified chemicals-and-materials holding company under the Mitsubishi Friday Meeting (Kinyokai) coordination umbrella. Its wealth origin is corporate: retained earnings, operating cash flow, and credit facilities routed through its primary banking partner Mitsubishi UFJ Financial Group. The Palace Building at 1-1-1 Marunouchi serves as group headquarters, while the Americas operation runs from 655 Third Avenue in New York. Deployment concentrates on three segments — performance products, industrial materials, and healthcare — with heavy exposure to carbon fiber, epoxy resins, petrochemicals, and pharmaceutical intermediates. The firm announced in May 2026 it is studying a carve-out of its petrochemical business into a separate entity, signaling a pivot toward higher-margin specialty chemicals. On the venture and innovation side, Mitsubishi Chemical formed a joint venture with Accenture in May 2026 to embed AI across business-support functions. It maintains a global R&D footprint spanning Japan, the United States, and additional unnamed regions, and exhibits at space-industry trade shows including SPEXA 2026. Total deployment figures are not publicly disclosed, but the firm discloses 26 named group companies anchored by three listed entities: Mitsubishi Chemical Group Corporation, Mitsubishi Chemical Corporation, and Nippon Sanso Holdings Corporation. Adjacent vehicles include two philanthropic foundations — the Mitsubishi Memorial Foundation for Educational Excellence and The Mitsubishi Foundation — alongside cultural assets such as the Mitsubishi Ichigokan Museum. In May 2026, President Chikamoto received the 2026 International Palladium Medal, a peer-awarded honor for contributions to the chemical industry. What distinguishes Mitsubishi Chemical Group from a standalone industrial corporation is its membership in the Mitsubishi Friday Meeting, which ties it to co-investors Mitsubishi Corporation, Mitsubishi Heavy Industries, and MUFG. This cross-shareholding architecture means strategic co-deployment — especially in aerospace materials and carbon-fiber supply chains — is a structural feature, not an episodic partnership.

## Sectors

- Industrial Tech
- Healthcare Services
- Energy Transition & Renewables
- SpaceTech

## Offices

- 655 Third Avenue, 15th Floor, New York, NY 10017, USA
- 1-3-26 Koyama, Shinagawa-ku, Tokyo 142-8558, Japan

## People

- Manabu Chikamoto — Representative Executive Officer, President & CEO

## Questions

### What role does the Mitsubishi keiretsu play in the firm’s investment posture?

Mitsubishi Chemical Group is a core member of the Mitsubishi Friday Meeting (Kinyokai), the coordination body linking Mitsubishi Corporation, Mitsubishi Heavy Industries, and MUFG. This relationship enables co-investment in aerospace materials, carbon-fiber supply chains, and shared R&D programs — effectively creating an internal co-investor club not available to outside institutional allocators.

### Which sectors does Mitsubishi Chemical Group actively develop?

Three pillars dominate: performance products (carbon fiber, specialty films), industrial materials (petrochemicals, epoxy resins, coke), and healthcare (pharmaceuticals and pharma intermediates). Recent evidence includes space-industry trade-show participation at SPEXA 2026, signaling an active interest in space-grade materials.

### What is the firm’s known posture on external co-investments alongside third-party GPs?

The firm does not publicly market itself as a third-party LP. Its default co-investment model is keiretsu-internal, co-deploying with Mitsubishi Corporation or Mitsubishi Heavy Industries — as it does in carbon-fiber supply chains and aerospace materials. External fund commitments, if they exist, are not a disclosed part of its investment strategy.

## Related profiles

- [MIT Solve](https://altss.com/profile/mit-solve)
- [Mitsubishi Estate](https://altss.com/profile/mitsubishi-estate)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/mitsubishi-chemical-group

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology